Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
Daniel SontupeMarket Access
Brenda SnowAuthentic Patient Voice
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
ADVM-022 is the first intravitreally delivered gene therapy utilizing directed evolution AAV.7m8 vector for ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email